Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NEOGENOMICS, INC.

(NEO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo NeoGenomics, Inc.
NeoGenomics, Inc. is an operator of a network of cancer-focused testing laboratories. The CompanyÔÇÖs customers include Clinical and Pharma. Its Clinical customers include community-based pathology practices, oncology groups, hospitals and academic centers. Its Pharma customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials. The Company offers testing services, which include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC) and digital imaging, molecular testing and morphologic analysis. The Company' Pharma Services segment provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. It helps its customers develop a biomarker hypothesis by recommending an optimal platform for molecular screening and backing its discovery tools with the informatics to capture meaningful data.

Number of employees : 1 700 people.
Sales per Business
20192020Delta
Clinical Testing361.1688.3%382.3486% +5.86%
Pharma Services47.6711.7%62.1114% +30.3%
USD in Million
Sales per region
20192020Delta
United States408.83100%444.45100% +8.71%
USD in Million
Managers
Name Title Age Since
Mark Mallon Chief Executive Officer & Director 57 2021
George Cardoza President & Chief Operating Officer-Lab Operations 58 2021
Kathryn McKenzie Chief Financial Officer 35 2020
Steven Ross Chief Information Officer & Vice President 56 -
Forrest Holmes Blocker Director-Scientific Affairs - -
John Mooney Chief Technology Officer - 2021
Stephanie Bywater Chief Compliance Officer 49 2018
Kevin C. Johnson Independent Director 65 2012
Bruce K. Crowther Independent Director 68 -
Lynn Tetrault Non-Executive Chairman 57 2021
Members of the board
Name Title Age Since
Lynn Tetrault Non-Executive Chairman 57 2021
Kevin C. Johnson Independent Director 65 2012
Bruce K. Crowther Independent Director 68 -
Alison L. Hannah, Dr. Independent Director 59 -
Stephen M. Kanovsky Independent Director 57 2017
Rachel Stahler Independent Director 44 2020
Michael Anthony Kelly Independent Director 63 2020
Mark Mallon Chief Executive Officer & Director 57 2021
David J. Daly Director 58 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 123,122,449 118,248,055 96.0% 0 0.0% 96.0%
Shareholders
NameEquities%
General Electric Co. (Investment Company) 15,000,000 12.2%
The Vanguard Group, Inc. 12,336,633 10.0%
Wellington Management Co. LLP 7,585,848 6.18%
Artisan Partners LP 6,931,041 5.64%
Janus Capital Management LLC 4,372,496 3.56%
SSgA Funds Management, Inc. 3,580,742 2.92%
BlackRock Fund Advisors 3,269,885 2.66%
Invesco Advisers, Inc. 2,723,448 2.22%
Douglas Van Oort 2,483,797 2.02%
Geode Capital Management LLC 2,038,725 1.66%
Company contact information
NeoGenomics, Inc.
12701 Commonwealth Drive
Suite 9
Fort Myers, FL 33913

Phone : +1.239.768.0600
Fax : +1.239.690.4237
Web : http://www.neogenomics.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of NeoGenomics, Inc.